The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patients' preferences for adjuvant sorafenib after resection of intermediate or high-risk renal cell carcinoma in the SORCE trial: What makes it worthwhile?
 
Prunella Louise Blinman
No Relationships to Disclose
 
Ian D. Davis
No Relationships to Disclose
 
Andrew Martin
No Relationships to Disclose
 
Simon Troon
No Relationships to Disclose
 
Shomik Sengupta
No Relationships to Disclose
 
Elizabeth J. Hovey
Consulting or Advisory Role - Bayer; Janssen; Pfizer; Sanofi
 
Xanthi Coskinas
No Relationships to Disclose
 
Richard S. Kaplan
No Relationships to Disclose
 
Alastair W. S. Ritchie
No Relationships to Disclose
 
Angela M. Meade
No Relationships to Disclose
 
Tim Eisen
No Relationships to Disclose
 
Martin R. Stockler
No Relationships to Disclose